Vancomycin ototoxicity in patients with normal renal function

Area of Science:

• Nephrology
• Ototoxicology
• Pharmacology

Background:

• Vancomycin is a critical antibiotic for treating serious Gram-positive bacterial infections.
• Renal function is a primary factor in vancomycin dosing and toxicity monitoring.
• Established guidelines aim to maintain therapeutic vancomycin levels while minimizing nephrotoxicity and ototoxicity.

Observation:

• Three patients with preserved renal function experienced documented ototoxicity.
• Ototoxicity manifested during standard vancomycin treatment regimens.
• These cases highlight a potential disconnect between perceived safety and clinical outcomes.

Findings:

• Ototoxicity occurred in patients with normal renal function, suggesting non-renal mechanisms.
• The incidence of vancomycin-induced ototoxicity may be underestimated in specific patient populations.
• This challenges the assumption that normal renal function guarantees vancomycin safety.

Implications:

• Clinical practice may need to reconsider "safe" vancomycin dosing thresholds.
• Enhanced monitoring for ototoxicity is warranted, irrespective of renal status.
• Further research into vancomycin ototoxicity mechanisms is crucial for patient safety.